AR058313A1 - Formulacion de profarmacos para el vhc - Google Patents
Formulacion de profarmacos para el vhcInfo
- Publication number
- AR058313A1 AR058313A1 ARP060105459A ARP060105459A AR058313A1 AR 058313 A1 AR058313 A1 AR 058313A1 AR P060105459 A ARP060105459 A AR P060105459A AR P060105459 A ARP060105459 A AR P060105459A AR 058313 A1 AR058313 A1 AR 058313A1
- Authority
- AR
- Argentina
- Prior art keywords
- block copolymer
- solid suspension
- peg
- melting point
- ppg
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente está relacionada con una composicion farmacéutica que contiene una suspension solida preparada mediante extrusion por fusion en calor de isobutirato de (2R, 3S, 4R, 5R)-5-(4-amino-2-oxo-2H-pirimidin-1-il)-2-azido-3,4-bis-iso-butiriloxi- tetrahidro-furan-2-ilmetilo; clorhidrato (1) y un copolímero de bloques de polietilenglicol (PEG)/polipropilenglicol (PPG). Reivindicacion 13: Un proceso de preparacion de una suspension solida de (1) y un copolímero de bloque de PEG/PPG que comprende los siguientes pasos: (i) mezclar los solidos en una mezcladora; (ii) introducir la mezcla de solidos resultante en una zona calefactora de la extrusora de fusion en caliente en la que la temperatura de la zona calefactora está en un rango superior al punto de fusion de dicho copolímero de bloques e inferior al punto de fusion de (1); (iii) extruir el material fundido resultante; y (iv) moler la suspension solida hasta un tamano de partícula de entre unas 20 y unas 2000 micras.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75014605P | 2005-12-14 | 2005-12-14 | |
US83059406P | 2006-07-12 | 2006-07-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR058313A1 true AR058313A1 (es) | 2008-01-30 |
Family
ID=37806115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060105459A AR058313A1 (es) | 2005-12-14 | 2006-12-12 | Formulacion de profarmacos para el vhc |
Country Status (21)
Country | Link |
---|---|
US (1) | US7795237B2 (es) |
EP (1) | EP1962808B1 (es) |
JP (1) | JP5649783B2 (es) |
KR (1) | KR20080089344A (es) |
AR (1) | AR058313A1 (es) |
AT (1) | ATE482690T1 (es) |
AU (1) | AU2006326130B2 (es) |
BR (1) | BRPI0619890A2 (es) |
CA (1) | CA2631498A1 (es) |
CR (1) | CR10026A (es) |
DE (1) | DE602006017257D1 (es) |
DK (1) | DK1962808T3 (es) |
EC (1) | ECSP088528A (es) |
IL (1) | IL191791A (es) |
MA (1) | MA30056B1 (es) |
NO (1) | NO20082563L (es) |
PL (1) | PL1962808T3 (es) |
PT (1) | PT1962808E (es) |
RU (1) | RU2435592C2 (es) |
TW (1) | TWI382840B (es) |
WO (1) | WO2007068615A2 (es) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005072710A2 (en) * | 2004-01-28 | 2005-08-11 | Johns Hopkins University | Drugs and gene carrier particles that rapidly move through mucous barriers |
PL2054040T3 (pl) * | 2006-08-16 | 2011-09-30 | Novartis Ag | Sposób wytwarzania stałych dyspersji midostauryny |
WO2008030557A2 (en) * | 2006-09-08 | 2008-03-13 | Johns Hopkins University | Compositions and methods for enhancing transport through mucus |
WO2008119659A2 (en) * | 2007-03-29 | 2008-10-09 | F. Hoffmann-La Roche Ag | Pharmaceutical composition and process |
PE20120020A1 (es) * | 2009-01-21 | 2012-02-02 | Hoffmann La Roche | Composicion farmaceutica que comprende un profarmaco inhibidor de la polimerasa de vhc |
AR075180A1 (es) * | 2009-01-29 | 2011-03-16 | Novartis Ag | Formulaciones orales solidas de una pirido-pirimidinona |
GB0909680D0 (en) | 2009-06-05 | 2009-07-22 | Euro Celtique Sa | Dosage form |
DK2528930T3 (da) | 2010-01-28 | 2013-11-11 | Hoffmann La Roche | 4'-azido-nukleosider som anti-hcv-forbindelser |
GB2492037A (en) | 2010-05-10 | 2012-12-19 | Euro Celtique Sa | Pharmaceutical compositions comprising hydromorphone and naloxone |
US9993433B2 (en) | 2010-05-10 | 2018-06-12 | Euro-Celtique S.A. | Manufacturing of active-free granules and tablets comprising the same |
US9901540B2 (en) | 2010-05-10 | 2018-02-27 | Euro-Celtique S.A. | Combination of active loaded granules with additional actives |
WO2012061703A1 (en) * | 2010-11-05 | 2012-05-10 | The Johns Hopkins University | Compositions and methods relating to reduced mucoadhesion |
WO2012062691A1 (en) * | 2010-11-09 | 2012-05-18 | F. Hoffmann-La Roche Ag | Pharmaceutical compositions for treating hcv infections |
EP2455068A1 (en) * | 2010-11-09 | 2012-05-23 | F. Hoffmann-La Roche AG | Pharmaceutical composition for treating HCV infections |
JP5917964B2 (ja) * | 2012-03-19 | 2016-05-18 | 富士ゼロックス株式会社 | 錠剤、錠剤の製造方法、錠剤管理装置、錠剤照合装置及びプログラム |
US11596599B2 (en) | 2012-05-03 | 2023-03-07 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
EP2844227B1 (en) | 2012-05-03 | 2020-11-18 | Kala Pharmaceuticals, Inc. | Pharmaceutical nanoparticles showing improved mucosal transport |
US9827191B2 (en) * | 2012-05-03 | 2017-11-28 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
EP4008355A1 (en) * | 2012-05-03 | 2022-06-08 | Kala Pharmaceuticals, Inc. | Pharmaceutical nanoparticles showing improved mucosal transport |
AU2014216178B2 (en) | 2013-02-15 | 2018-06-28 | KALA BIO, Inc. | Therapeutic compounds and uses thereof |
EP3763710A1 (en) | 2013-02-20 | 2021-01-13 | Kala Pharmaceuticals, Inc. | Therapeutic compounds and uses thereof |
US9688688B2 (en) | 2013-02-20 | 2017-06-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof |
US9890173B2 (en) | 2013-11-01 | 2018-02-13 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
KR20160099084A (ko) | 2013-11-01 | 2016-08-19 | 칼라 파마슈티컬스, 인크. | 치료 화합물의 결정질 형태 및 그의 용도 |
AU2014350135B2 (en) | 2013-11-13 | 2017-08-31 | Euro-Celtique S.A. | Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome |
CA3036336A1 (en) | 2016-09-08 | 2018-03-15 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
US10392399B2 (en) | 2016-09-08 | 2019-08-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
AU2017324251A1 (en) | 2016-09-08 | 2019-03-21 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
EP3381479A1 (de) * | 2017-03-29 | 2018-10-03 | ARTOSS GmbH | Trägerzusammensetzung für knochenersatzmaterialien |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2325046T3 (es) | 1996-06-26 | 2009-08-24 | The Board Of Regents, The University Of Texas System | Formulacion farmaceutica extruible por fusion en caliente. |
ATE232087T1 (de) * | 1997-10-27 | 2003-02-15 | Merck Patent Gmbh | Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes |
MXPA03009971A (es) * | 2001-05-03 | 2004-02-12 | Hoffmann La Roche | FORMA DE DOSIFICACIoN FARMACEUTICA DE MESILATO DE NELFINAVIR AMORFO. |
DE10208344A1 (de) | 2002-02-27 | 2003-09-04 | Roehm Gmbh | Schmelzextrusion von Wirkstoffsalzen |
TWI332507B (en) * | 2002-11-19 | 2010-11-01 | Hoffmann La Roche | Antiviral nucleoside derivatives |
US20050044529A1 (en) | 2003-08-20 | 2005-02-24 | Microsoft Corporation | Task library of task data for a plurality of components on a computer system |
US20050048112A1 (en) | 2003-08-28 | 2005-03-03 | Jorg Breitenbach | Solid pharmaceutical dosage form |
-
2006
- 2006-12-04 PL PL06830328T patent/PL1962808T3/pl unknown
- 2006-12-04 KR KR1020087014073A patent/KR20080089344A/ko not_active Application Discontinuation
- 2006-12-04 PT PT06830328T patent/PT1962808E/pt unknown
- 2006-12-04 CA CA002631498A patent/CA2631498A1/en not_active Abandoned
- 2006-12-04 DK DK06830328.8T patent/DK1962808T3/da active
- 2006-12-04 AT AT06830328T patent/ATE482690T1/de active
- 2006-12-04 RU RU2008128361/15A patent/RU2435592C2/ru not_active IP Right Cessation
- 2006-12-04 DE DE602006017257T patent/DE602006017257D1/de active Active
- 2006-12-04 JP JP2008544952A patent/JP5649783B2/ja not_active Expired - Fee Related
- 2006-12-04 EP EP06830328A patent/EP1962808B1/en active Active
- 2006-12-04 WO PCT/EP2006/069262 patent/WO2007068615A2/en active Application Filing
- 2006-12-04 BR BRPI0619890-2A patent/BRPI0619890A2/pt not_active IP Right Cessation
- 2006-12-04 AU AU2006326130A patent/AU2006326130B2/en not_active Ceased
- 2006-12-12 AR ARP060105459A patent/AR058313A1/es not_active Application Discontinuation
- 2006-12-12 TW TW095146501A patent/TWI382840B/zh not_active IP Right Cessation
- 2006-12-13 US US11/637,999 patent/US7795237B2/en not_active Expired - Fee Related
-
2008
- 2008-05-28 IL IL191791A patent/IL191791A/en not_active IP Right Cessation
- 2008-05-28 CR CR10026A patent/CR10026A/es not_active Application Discontinuation
- 2008-06-02 NO NO20082563A patent/NO20082563L/no not_active Application Discontinuation
- 2008-06-12 EC EC2008008528A patent/ECSP088528A/es unknown
- 2008-06-16 MA MA31038A patent/MA30056B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0619890A2 (pt) | 2011-10-25 |
CA2631498A1 (en) | 2007-06-21 |
TW200803873A (en) | 2008-01-16 |
DE602006017257D1 (de) | 2010-11-11 |
DK1962808T3 (da) | 2010-11-08 |
AU2006326130A1 (en) | 2007-06-21 |
TWI382840B (zh) | 2013-01-21 |
JP5649783B2 (ja) | 2015-01-07 |
WO2007068615A2 (en) | 2007-06-21 |
PT1962808E (pt) | 2010-10-29 |
MA30056B1 (fr) | 2008-12-01 |
PL1962808T3 (pl) | 2011-03-31 |
AU2006326130B2 (en) | 2011-09-22 |
RU2435592C2 (ru) | 2011-12-10 |
US7795237B2 (en) | 2010-09-14 |
IL191791A0 (en) | 2008-12-29 |
JP2009519289A (ja) | 2009-05-14 |
NO20082563L (no) | 2008-07-03 |
ATE482690T1 (de) | 2010-10-15 |
WO2007068615A3 (en) | 2007-09-07 |
US20070202175A1 (en) | 2007-08-30 |
IL191791A (en) | 2011-06-30 |
EP1962808B1 (en) | 2010-09-29 |
KR20080089344A (ko) | 2008-10-06 |
RU2008128361A (ru) | 2010-01-20 |
CR10026A (es) | 2008-07-29 |
ECSP088528A (es) | 2008-07-30 |
EP1962808A2 (en) | 2008-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR058313A1 (es) | Formulacion de profarmacos para el vhc | |
ES2205559T3 (es) | Procedimiento para el moldeo de gel orientado de una composicion de resina de poliolefina y objeto moldeado obtenido mediante dicho procedimiento. | |
EA200801466A1 (ru) | Устройство и способ переработки с контролируемым гранулированием | |
BR0210059A (pt) | Cola de fusão na forma de um granulado | |
ES2624796T3 (es) | Composición de agente de nucleación de forma cristalina ß para polipropileno y aplicación de la misma | |
EP0818292A2 (en) | Process for preparing expanded product of thermoplastic resin | |
ES2370640T3 (es) | Redes poliméricas. | |
CN1898317B (zh) | 用于控制聚烯烃类树脂结晶速度的组合物和方法、树脂组合物和树脂成型品 | |
WO1999018108A1 (fr) | Composition de diacetal, procede de preparation, agent de nucleation pour polyolefines contenant une telle composition, compositions de resines de polyolefines, et moulages | |
PE20060652A1 (es) | Composiciones farmaceuticas de liberacion inmediata que comprenden granulos de fusion | |
CA2454595A1 (en) | Sulfur additives for paving binders and manufacturing methods | |
IL173304A (en) | Closure for vial or plunger for syringe | |
DE60302435D1 (de) | Leitfähige vormischung und leitfähige harzzusammensetzung | |
KR950018239A (ko) | 자유 유동성 분말 조성물, 그의 제조 방법 및 그로부터 유도된 균질층 | |
ES2359407T3 (es) | Composición de resina para pavimentación y método para producir una composición asfáltica para pavimentación. | |
WO2002098391A3 (en) | Process for preparing granular compositions | |
RU2009142206A (ru) | Способ изготовления свечей | |
KR910009792A (ko) | 압출-과립화-분쇄에 의해 감열 호변성 중합체 분말을 제조하는 방법. 분쇄되어 이들 분말을 제조하는 과립물 및 수득된 자유 유동성 미세분말 | |
Cimmino et al. | Isotactic polypropylene/hydrogenated oligo (cyclopentadiene) blends: phase diagram and dynamic-mechanical behaviour of extruded isotropic films | |
US11873582B2 (en) | Filaments for 3D printing | |
ES2282509T3 (es) | Procedimiento de produccion de una composicion termoplastica a base de alcohol polivinilico exenta de particulas infundidas y de degradac ion. | |
KR102404999B1 (ko) | 열가소성 사출 성형 및 물풀림성 재료 | |
CN102140248B (zh) | 注射成型用液晶性树脂组合物、成型体及方法 | |
DK1230197T3 (da) | Fremgangsmåde til fremstilling af sammensatte gødningsstofgranulater | |
Al‐raheil et al. | Isotactic polypropylene crystallized from the melt. II. Thermal melting behavior |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |